Sort   by:  
 Page size 
ProteomicsCharacterization of the mitochondrial proteome of human cells (MitoCoP)
The overall aim of the project is the definition and characterization of the mitochondrial proteome of human cells, referred to as MitoCoP. To this end, we combined the complementary strengths of subtractive proteomics, ImportOmics and subcellular protein profiling in a global multidimensional class...
ORGANISM(S): Homo sapiens (Human) 
2021-11-25 | PXD028149 | Pride
Mitochondria Silac Subtractive proteomics Complexome profiling 
UnknownModeling Novel Putative Drugs and Vaccine Candidates against Tick-Borne Pathogens: A Subtractive Proteomics Approach.
Not available
S-EPMC7557734 | biostudies-literature
UnknownAnti-Vibrio parahaemolyticus compounds from Streptomyces parvus based on Pan-genome and subtractive proteomics.
Not available
S-EPMC10361664 | biostudies-literature
UnknownSubtractive proteomics assisted therapeutic targets mining and designing ensemble vaccine against Candida auris for immune response induction.
Not available
S-EPMC8971067 | biostudies-literature
ProteomicsDefinition and characterization of the mitochondrial proteome of human cells (MitoCoP)
Aim of this project was the definition and characterization of the mitochondrial proteome of human cells, referred to as MitoCoP. To this end, we combined the complementary strengths of subtractive proteomics, ImportOmics and subcellular protein profiling in a global multidimensional classification ...
ORGANISM(S): Homo sapiens (Human) 
2021-11-25 | PXD016924 | Pride
Proteomics Silac Subtractive proteomics Mitochondria Spatial proteomics Pulsed silac Importomics Complexome profiling Rnai-mediated protein knockdown 
ProteomicsA Subtractive Proteomics Approach for the Identification of Immunodominant Acinetobacter baumannii Vaccine Candidate Proteins
Background: Acinetobacter baumannii is one of the most dangerous multidrug-resistant pathogens worldwide. Currently, 50-70% of clinical isolates of A. baumannii are extensively drug-resistant (XDR) and available antibiotic options against A. baumannii infections are limited. There are still needs to...
ORGANISM(S): Acinetobacter baumannii AYE Acinetobacter baumannii (strain ATCC 17978 / CIP 53.77 / LMG 1025 / NCDC KC755 / 5377) 
2022-11-02 | PXD037507 | Pride
Immunodominant Vaccine candidate Immunoprecipitation Acinetobacter baumannii (a. baumannii) Proteomics 
UnknownSubtractive proteomics to identify novel drug targets and reverse vaccinology for the development of chimeric vaccine against Acinetobacter baumannii.
Not available
S-EPMC5997985 | biostudies-literature
UnknownIntegrated Core Proteomics, Subtractive Proteomics, and Immunoinformatics Investigation to Unveil a Potential Multi-Epitope Vaccine against Schistosomiasis.
Not available
S-EPMC8235758 | biostudies-literature
UnknownMurG as a potential target of quercetin in Staphylococcus aureus supported by evidence from subtractive proteomics and molecular dynamics.
Not available
S-EPMC11873250 | biostudies-literature
UnknownAn integrated comparative genomics, subtractive proteomics and immunoinformatics framework for the rational design of a Pan-Salmonella multi-epitope vaccine.
Not available
S-EPMC11221655 | biostudies-literature
Sort   by:  
 Page size